Use of antidiabetes agents in pregnancy: Current practice and controversy

Journal of Perinatal and Neonatal Nursing

Volumn 16, Issue 2, 2002, Pages 40-53

  Slocum, Julie M ^b   Sosa, Mary Ellen Burke ^a  

^a Perinatal Resources   (United States)

^b NONE

Author keywords

Diabetes in pregnancy; Gestational diabetes; Maternal fetal health; Obstetrics; Oral hypoglycemic agents

Indexed keywords

ALPHA GLUCOSIDASE; ANTIDIABETIC AGENT; BENZAMIDE DERIVATIVE; BIGUANIDE DERIVATIVE; ENZYME INHIBITOR; MEGLITINIDE; SULFONYLUREA DERIVATIVE; THIAZOLE DERIVATIVE;

DRUG ANTAGONISM; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; OVARY POLYCYSTIC DISEASE; PREGNANCY; PREGNANCY DIABETES MELLITUS; REVIEW;

ADMINISTRATION, ORAL; ALPHA-GLUCOSIDASES; BENZAMIDES; BIGUANIDES; DIABETES, GESTATIONAL; ENZYME INHIBITORS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY IN DIABETICS; SULFONYLUREA COMPOUNDS; THIAZOLES;

EID: 0042370162     PISSN: 08932190     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005237-200209000-00005     Document Type: Article

References (41)

1. Reece EA, Coustan DR. Diabetes Mellitus in Pregnancy. 2nd ed. New York: Churchill Livingstone; 1995.
2. Jovanovic L. Medical Management of Pregnancy Complicated by Diabetes. 3rd ed. Alexandria, VA: American Diabetes Association; 2000.
3. Langer O, Conway DL, Berkus MD, Xenakis M, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med. 2000;343:1134-1138.
4. Kitzmiller J. Limited efficacy of glyburide for glycemic control. Am J Obstet Gynecol. 2001;185:S198.
5. Chmait R, Dinise T, Daneshmand S, Kim M, Moore T. Prospective cohort study to establish predictors of glyburide success in gestational diabetes mellitus. Am J Obstet Gynecol. 2001;185:S197.
6. Glueck CJ, Phillips H, Cameron D, Sieve-Smith L, Wang P. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study. Fertil Steril. 2001; 75:46-52.
7. Jakubowicz DJ, Iurono MJ, Jakubowicz S, Roberts KA, Nestler JE. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87:524-529.
8. American Diabetes Association. Clinical practice recommendations 2002. Diabetes Care. 2002;25:S1-S140.
9. American College of Obstetricians and Gynecologists. Practice Bulletin: Gestational Diabetes. Washington, DC: ACOG; 2001.
10. Metzger BE, Coustan DR. Summary and recommendations of the fourth international workshop-conference of gestational diabetes mellitus. Diabetes Care. 1998;21: 161B-167B.
11. Kemball ML, McIver C, Milner RD, Nourse CH, Schiff D, Tiernan JR. Neonatal hypoglycaemia in infants of diabetic mothers given sulphonylurea drugs in pregnancy. Arch Dis Child. 1970;45:696-701.
12. Harris EL. Adverse reactions to oral antidiabetic agents. Br Med J. 1971;3:29-30.
13. Committee on Drugs, American Academy of Pediatrics. The transfer of drugs and other chemicals into human milk. Pediatrics. 1994;93:137-150.
14. Sutherland HW, Bewsher PD, Cormack JD, et al. Effect of moderate dosage of chlorpropamide in pregnancy on fetal outcome. Arch Dis Child. 1974;49:283-291.
15. Piacquadio K. Hollingsworth DR, Murphy H. Effects of in-utero exposure to oral hypoglycaemic drugs. Lancet. 1991;338:866-869.
16. Towner D, Kjos SL, Leung B, et al. Congenital malformations in pregnancies complicated by NIDDM. Diabetes Care. 1995;18:1446-1451.
17. Langer O, Conway D, Berkus M, Xenakis E. There is no association between oral hypoglycemic use and fetal anomalies. Am J Obstet Gynecol 1999;180:38S.
18. Federal Register. 1980;44:37434-37467.
19. Gerich JE. Oral hypoglycemic agents. N Engl J Med. 1989:321:1231-1245.
20. Hardman JG, Limbird LE. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 9th ed. New York: McGraw-Hill; 1996.
21. Elliott BD, Schenker S, Langer O, Johnson R, Prihoda T. Comparative placental transport of oral hypoglycemic agents in humans: a model of human placental drug transfer. Am J Obstet Gynecol. 1994;171: 653-660.
22. Franz MJ. A Core Curriculum for Diabetes Education: Diabetes Management Therapies. 4th ed. Chicago: American Association of Diabetes Educators; 2001.
23. Bailey CJ, Turner RC. Metformin. N Engl J Med. 1996;9:574-579.
24. Notelovitz MB. Sulphonylurea therapy in the treatment of the pregnant diabetic. S Afr Med J. 1971;45:226-229.
25. Coetzee EJ, Jackson WP. Oral hypoglycaemics in the first trimester and fetal outcome. S Afr Med J. 1984;65:635-637.
26. Hellmuth E, Damm P, Molsted-Pederson L. Oral hypoglycaemic agents in 118 diabetic pregnancies. Diabetic Med. 2000;17:507-511.
27. Elliott BD, Langer O, Schenker S, Johnson RF. Insignificant transfer of glyburide occurs across the human placenta. Am J Obstet Gynecol. 1991;165:807-812.
28. Elliott BS, Langer O, Schuessling F. Human placental glucose uptake and transport are not altered by the oral antihyperglycemic agent metformin. Am J Obstet Gynecol. 1997;176:527-530.
29. Seale FG, Robinson RD, Neal GS. Association of metformin and pregnancy in the polycystic ovary syndrome: a report of three cases. J Reprod Med. 2000;45:507-510.
30. Kocak M, Caliskan E, Simsir C, Haberal A. Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome. Fertil Steril. 2002;77:101-106.
31. Vandermolen DT, Ratts VS, Evans WS, Stovall DW, Kauma SW, Nestler JE. Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertil Steril. 2001;2:310-315.
32. Cataldo NA, Abbasi F, McLaughlin TL, Lamendola C, Reaven GM. Improvement in insulin sensitivity followed by ovulation and pregnancy in a woman with polycystic ovary syndrome who was treated with rosiglitazone. Fertil Steril. 2001;76:1057-1059.
33. Greene MF. Oral hypoglycemic drugs for gestational diabetes. N Engl J Med. 2000;343:1178-1179. Editorial.
34. Dornhorst A. A comparison of glyburide and insulin in women with gestational diabetes mellitus. Diabetic Med. 2001;18:12-14.
35. Koren G. The use of glyburide in gestational diabetes - an ideal example of "bench to bedside." Pediatr Res. 2001;49:734.
36. Coustan DR. Oral hypoglycemic agents for the ob/gyn. Contemp OB/GYN. 2001;2:44-63.
37. Cefalo RC. A comparison of glyburide and insulin in women with gestational diabetes mellitus. Obstet Gynecol Surv. 2001;56:126-127.
38. Wilton LV, Pearce GL, Martin RM, Mackay FJ, Mann RD. The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England. Br J Obstet Gynaecol. 1998;105:882-889.
39. Zarate A, Ochoa R, Hernandez M, Basurto L. Effectiveness of acarbose in the control of glucose tolerance worsening in pregnancy. Ginecol Obstet Mex. 2000;68:42-45.
40. Physicians' Desk Reference. 56th ed. Montvale, NJ: Medical Economics; 2002.
41. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 5th ed. Philadelphia: Williams & Wilkins; 1998.